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Diabetes mellitus (DM) is a growing
problem, with an estimated global preva-
lence of 9.9% or 552 million adults
affected in 2030 [1]. Evidence from
randomised controlled trials has proved
that several interventions, such as lifestyle
changes or anti-diabetic medications, can
significantly delay or prevent the occur-
rence of DM in women with impaired
glucose intolerance [2]. Identification of
risk factors for developing DM is therefore
crucial in daily practice since screening
high-risk populations for DM and im-
paired glucose tolerance, with appropriate
interventions for those with impaired
glucose tolerance, has been deemed cost
effective [3]. A Canadian cohort study in
this week’s PLOS Medicine [4] provides
valuable new evidence on preeclampsia
(PEC) and the impetus for discussing
whether it is now time to consider
screening women with a history of hyper-
tensive pregnancy disorders.
Gestational diabetes (GDM) is known as
a strong risk factor for subsequent diabetes
[5], and women with GDM have been
consistently recommended to undergo
postpartum screening for DM [6,7]. Like
GDM, hypertensive pregnancy disorders
have been found to be associated with
insulin resistance, which plays an impor-
tant role in the aetiology of type 2 DM [8],
making the group of women with a history
of hypertensive disorders in pregnancy a
potential candidate for DM prevention
programs. Hypertension is more common-
ly identified than GDM in pregnancy [9].
In a recent international comparative
report [9], hypertension was noted in 9%
of pregnancies in Australia, 7% in the
United States, and 4% in Sweden, com-
pared with GDM in 4.8%, 4.4%, and
0.9% of pregnancies, respectively.
It has been shown that hypertensive
disorders in pregnancy, especially PEC,
are independently associated with an
elevated risk of women subsequently
developing DM [10–12]. However, the
presence of GDM was not taken into
account in these previous studies, making
clinical interpretation difficult. The new
study in PLOS Medicine, a population-based
retrospective cohort study by Denise Feig
and colleagues [4], helps overcome this
challenge by examining whether hyper-
tensive pregnancy disorders, including
both gestational hypertension (GH) and
PEC, increase the risk of subsequent
development of DM in the absence of
GDM, and how the risks would be
changed in the presence of GDM.
Hypertensive Pregnancy
Disorders Alone Doubled the
Risk of Developing Diabetes
In Feig and colleagues’ study, the cohort
of one million women aged 15 to 50 years
who delivered in Ontario, Canada, was
followed with a median follow-up of 8.5
years [4]. Hypertensive disorders in preg-
nancy were categorised into four mutually
exclusive groups: GE alone, PE alone, GE
and GDM, and PEC and GDM, using the
hospitalization records and outpatient data
from physicians’ services claims. Diabetes
was determined using the Ontario Diabe-
tes Database, which had been well vali-
dated against primary health care charts.
A Cox proportional regression was carried
out to make an adjustment for potential
confounding effects, including maternal
age, prior hypertension, socioeconomic
status, parity, and co-morbidity. Hyper-
tensive disorders in pregnancy were found
to double the risk of developing DM until
16 years after delivery in the absence of
GDM, but to confer an almost 20-fold
increased risk in the presence of GDM.
Approximately 25% of women with GDM
and hypertensive disorders are reported to
have developed diabetes within the first 5
years following pregnancy, compared with
19% of women with only GDM.
The study is the largest population-
based report with successful and long-term
follow-up, and is the first to examine the
association between hypertensive disorders
during pregnancy and subsequent devel-
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Linked Research Article
This Perspective discusses the
following new study published in
PLOS Medicine:
Feig DS, Shah BR, Lipscombe LL, Wu
CF, Ray JG, et al. (2013) Preeclamp-
sia as a Risk Factor for Diabetes: A
Population-Based Cohort Study.
PLoS Med 10(4): e1001425. doi:10.
1371/journal.pmed.1001425
Denice Feig and colleagues assess
the association between gestational
diabetes, gestational hypertension,
and preeclampsia and the develop-
ment of future diabetes in a data-
base analysis of pregnant women in
Ontario, Canada.
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opment of diabetes, taking GDM into
consideration. As a result, its findings have
important clinical and public health im-
plications. However, there are several
limitations inherently associated with the
retrospective nature of the study. Most
importantly, some known risk factors for
the development of DM—such as obesity,
family history, physical activity, and glu-
cose and blood pressure measures—were
not available in the databases, and there-
fore could not be adjusted for. It is unlikely
that this limitation would alter the findings
significantly [10].




Given current trends in the prevalence
of DM and hypertension in pregnancy,
and their associated risk, it is time to
consider an appropriate action for women
with a history of hypertensive pregnancy
disorders. Currently, women with a histo-
ry of hypertensive disorders in pregnancy
would not be systematically screened for
diabetes for the following reasons.
Firstly, postpartum screening for DM,
which often focuses only on women with
GDM, has been sub-optimally implement-
ed [13], although it has been consistently
recommended for decades [6,7]. In Tovar
et al.’s study, only about half of eligible
women in most populations, varying from
34% to 73%, were found to undergo any
types of screening postpartum, including
fasting plasma glucose and oral glucose
tolerance tests [13]. Even in a setting with
a high overall screening rate of 73%, only
27% of women were screened accordingly
to the current guidelines [14]. Some
barriers to postpartum screening DM
might not be solved soon [13].
Secondly, there is currently a lack of
evidence of benefits of screening women
with hypertensive disorders in pregnancy
for DM. In fact, a policy for screening the
population of women at high risk for DM
but not impaired glucose intolerance, with
no intervention offered to those with
impaired glucose tolerance, was associated
with uncertain cost effectiveness [4].
How Should Women with
History of Hypertensive
Disorders in Pregnancy Be
Managed?
While the current evidence base does
not support the idea that women with a
history of hypertensive disorders in preg-
nancy be systematically screened for DM,
inaction is not an option either. Based
upon this new study, women experiencing
hypertensive pregnancy disorders with or
without GDM should be considered as a
population at high risk for subsequently
developing diabetes. All women with a
history of hypertensive disorders in preg-
nancy should thus be counselled about
their potential increased risk of subsequent
DM and the possible opportunity for
screening as well as preventive interven-
tions. Postpartum screening for DM
should be individualised. Current postpar-
tum screening programs should particu-
larly focus on women with GDM in
combination with hypertensive disorders.
Given their higher risk of developing
diabetes, it is crucial to exercise more
efforts to improve compliance of this high-
risk population to the current postpartum
screening for diabetes.
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